Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol and Lisinopril for Diabetic Kidney Protection
NCT07177898Completed
- Sponsor
- Narowal Medical College
- Start
- May 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of allopurinol in diabetic kidney disease (DKD), sponsored by Narowal Medical College. Primary endpoint: Urinary Albumin at 12 months. Started May 2023; status: completed.
02
Drugs
allopurinol
03
Conditions
diabetic kidney disease (DKD)
Beyond the preview
Go deeper on NCT07177898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07177898.